Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03990376 · ClinicalTrials.gov registry record · NA
Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT03990376 is a NA study that has completed, run by Emory University. The registered enrollment target is 30 participants.
The verdict
NCT03990376, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to establish a benchmark for measuring blood loss by directly measuring the change in red cell volume before and after surgery and to compare established blood loss estimators to this benchmark in order to determine the most accurate and precise method for estimating blood loss in adolescent idiopathic scoliosis surgery patients
Interventions
- OTHER Radioisotope I-131-labeled albumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-06-19 |
| Est. Completion | 2020-09-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03990376
The ClinicalTrials.gov registry entry for NCT03990376 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Radioisotope I-131-labeled albumin is the first listed.
NCT03990376 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03990376 about?
NCT03990376 is a clinical study titled "Adolescent Idiopathic Scoliosis (AIS) Gold Standard for Blood Loss". The purpose of this study is to establish a benchmark for measuring blood loss by directly measuring the change in red cell volume before and after surgery and to compare established blood loss estimators to this benchmark in order to determine the most accurate and precise method for estimating blo...
What is the current status of trial NCT03990376?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2019-06-19. Estimated completion is 2020-09-10.
What interventions are being tested in trial NCT03990376?
The interventions under investigation include: Radioisotope I-131-labeled albumin (OTHER).
Who is sponsoring clinical trial NCT03990376?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.